Citigroup’s ProKidney PROK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$11K Sell
18,537
-60,313
-76% -$35.7K ﹤0.01% 4437
2025
Q1
$69.1K Sell
78,850
-8,273
-9% -$7.25K ﹤0.01% 4013
2024
Q4
$147K Buy
87,123
+11,973
+16% +$20.2K ﹤0.01% 3787
2024
Q3
$144K Buy
75,150
+2,001
+3% +$3.84K ﹤0.01% 3809
2024
Q2
$180K Buy
73,149
+64,499
+746% +$159K ﹤0.01% 3223
2024
Q1
$14.2K Buy
8,650
+2,118
+32% +$3.47K ﹤0.01% 4366
2023
Q4
$11.6K Buy
6,532
+6,447
+7,585% +$11.5K ﹤0.01% 4396
2023
Q3
$389 Sell
85
-19,063
-100% -$87.2K ﹤0.01% 4479
2023
Q2
$214K Buy
19,148
+18,375
+2,377% +$206K ﹤0.01% 3200
2023
Q1
$8.75K Buy
773
+6
+0.8% +$68 ﹤0.01% 4123
2022
Q4
$5.26K Buy
+767
New +$5.26K ﹤0.01% 4292
2022
Q2
Sell
-47,100
Closed -$465K 5645
2022
Q1
$465K Sell
47,100
-100
-0.2% -$987 ﹤0.01% 2911
2021
Q4
$467K Hold
47,200
﹤0.01% 3109
2021
Q3
$463K Buy
+47,200
New +$463K ﹤0.01% 2944